News
December 18, 2017: 
-BPL has signed an agreement with a global company (Fortune500) to collaborate in the development of a new protein-based drug candidate.
According to the agreement, BPL will develop a bacterial fermentation, refolding process,
purification and formulation as well as the related analytical testing methods.
For this project, BPL will  utilize its know-how and experience in recombinant protein expression in bacterial systems, purification and product formulation.
 

 November 2017
-BPL has signed an agreement with US based company for the development and production of series of enzymes and their immobilization to solid matrices. BPL will utilize its know-how and experience in recomninant enzyme expression in bacterial systems, purification and product formulation.



-BPL is relocating to a new facility in Yavne- 15 Nahal Snir st. The facility, designed and constructed specially according to BPL's plans and requirements, will be ready by ebd December 2017. BPL will start operation in the new facility by beginning January 2018.





 
 
Mailing List

Please enter your e-mail address

 Send

 
Share
 

• BioPharm Laboratories is known worldwide for the quality of its services and products
• Our products based on innovation and have added value for our clients over the products of other suppliers.
• Our products are used in the most advanced registered Cell Therapy and Regenerative Medicine treatments and products
• Our services based on innovative and cutting edge technologies are used for the manufacturing of breakthrough biopharmaceutical products, either in our facilities or in customers’ manufacturing site

BPL Biologics     19 Hidekel st. Yavne POB 13240  8122614  Israel
Tel: +972.76.548.8118   US: +973.723.9000